PURPOSE: It has been hypothesized that vitamin D mediates the inverse relationship between sun exposure and non-Hodgkin lymphoma (NHL) risk reported in several recent studies. We evaluated the association of self-reported sun exposure at ages <13, 13-21, 22-40, and 41+ years and 19 single nucleotide polymorphisms (SNPs) from 4 candidate genes relevant to vitamin D metabolism (RXR, VDR , CYP24A1, CYP27B1) with NHL risk. METHODS: This analysis included 1,009 newly diagnosed NHL cases and 1,233 frequency-matched controls from an ongoing clinic-based study. Odds ratios (OR), 95 % confidence intervals (CI), and tests for trend were estimated using unconditional logistic regression. RESULTS: There was a significant decrease in NHL risk with increased sun exposure at ages 13-21 years (OR(≥15 vs. ≤3 h/week) = 0.68; 95 % CI, 0.43-1.08; p(trend) = 0.0025), which attenuated for older ages at exposure. We observed significant main effect associations for 3 SNPs in VDR and 1 SNP in CYP24A1: rs886441 (OR(per-allele) = 0.82; 95 % CI, 0.70-0.96; p = 0.016), rs3819545 (OR(per-allele) = 1.24; 95 % CI, 1.10-1.40; p = 0.00043), and rs2239186 (OR(per-allele) = 1.22; 95 % CI, 1.05-1.41; p = 0.0095) for VDR and rs2762939 (OR(per-allele) = 0.85; 95 % CI, 0.75-0.98; p = 0.023) for CYP24A1. Moreover, the effect of sun exposure at age 13-21 years on overall NHL risk appears to be modified by germline variation in VDR (rs4516035; p(interaction) = 0.0066). Exploratory analysis indicated potential heterogeneity of these associations by NHL subtype. CONCLUSION: These results suggest that germline genetic variation in VDR, and therefore the vitamin D pathway, may mediate an association between early life sun exposure and NHL risk.
PURPOSE: It has been hypothesized that vitamin D mediates the inverse relationship between sun exposure and non-Hodgkin lymphoma (NHL) risk reported in several recent studies. We evaluated the association of self-reported sun exposure at ages <13, 13-21, 22-40, and 41+ years and 19 single nucleotide polymorphisms (SNPs) from 4 candidate genes relevant to vitamin D metabolism (RXR, VDR , CYP24A1, CYP27B1) with NHL risk. METHODS: This analysis included 1,009 newly diagnosed NHL cases and 1,233 frequency-matched controls from an ongoing clinic-based study. Odds ratios (OR), 95 % confidence intervals (CI), and tests for trend were estimated using unconditional logistic regression. RESULTS: There was a significant decrease in NHL risk with increased sun exposure at ages 13-21 years (OR(≥15 vs. ≤3 h/week) = 0.68; 95 % CI, 0.43-1.08; p(trend) = 0.0025), which attenuated for older ages at exposure. We observed significant main effect associations for 3 SNPs in VDR and 1 SNP in CYP24A1: rs886441 (OR(per-allele) = 0.82; 95 % CI, 0.70-0.96; p = 0.016), rs3819545 (OR(per-allele) = 1.24; 95 % CI, 1.10-1.40; p = 0.00043), and rs2239186 (OR(per-allele) = 1.22; 95 % CI, 1.05-1.41; p = 0.0095) for VDR and rs2762939 (OR(per-allele) = 0.85; 95 % CI, 0.75-0.98; p = 0.023) for CYP24A1. Moreover, the effect of sun exposure at age 13-21 years on overall NHL risk appears to be modified by germline variation in VDR (rs4516035; p(interaction) = 0.0066). Exploratory analysis indicated potential heterogeneity of these associations by NHL subtype. CONCLUSION: These results suggest that germline genetic variation in VDR, and therefore the vitamin D pathway, may mediate an association between early life sun exposure and NHL risk.
Authors: Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher Journal: Cancer Invest Date: 2009-11 Impact factor: 2.176
Authors: Patricia Hartge; Unhee Lim; D Michal Freedman; Joanne S Colt; James R Cerhan; Wendy Cozen; Richard K Severson; Scott Davis Journal: Cancer Causes Control Date: 2006-10 Impact factor: 2.506
Authors: Ellen T Chang; Katarina M Bälter; Anna Torrång; Karin Ekström Smedby; Mads Melbye; Christer Sundström; Bengt Glimelius; Hans-Olov Adami Journal: Am J Epidemiol Date: 2006-09-27 Impact factor: 4.897
Authors: Thomas Weihkopf; Nikolaus Becker; Alexandra Nieters; Birte Mester; Evelin Deeg; Gine Elsner; Maria Blettner; Andreas Seidler Journal: Int J Cancer Date: 2007-06-01 Impact factor: 7.396
Authors: Mark P Purdue; D Michal Freedman; Susan M Gapstur; Kathy J Helzlsouer; Francine Laden; Unhee Lim; Gertraud Maskarinec; Nathaniel Rothman; Xiao-Ou Shu; Victoria L Stevens; Anne Zeleniuch-Jacquotte; Demetrius Albanes; Kimberly Bertrand; Stephanie J Weinstein; Kai Yu; Lonn Irish; Ronald L Horst; Judith Hoffman-Bolton; Edward L Giovannucci; Laurence N Kolonel; Kirk Snyder; Walter Willett; Alan A Arslan; Richard B Hayes; Wei Zheng; Yong-Bing Xiang; Patricia Hartge Journal: Am J Epidemiol Date: 2010-06-18 Impact factor: 4.897
Authors: Jennifer L Kelly; Zachary S Fredericksen; Mark Liebow; Tait D Shanafelt; Carrie A Thompson; Timothy G Call; Thomas M Habermann; William R Macon; Alice H Wang; Susan L Slager; James R Cerhan Journal: Ann Epidemiol Date: 2012-11-10 Impact factor: 3.797
Authors: Paige M Kulling; Kristine C Olson; Thomas L Olson; David J Feith; Thomas P Loughran Journal: Eur J Haematol Date: 2016-11-21 Impact factor: 2.997
Authors: Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers Journal: Expert Rev Anticancer Ther Date: 2015-04-11 Impact factor: 4.512
Authors: Bridget Charbonneau; Helen M O'Connor; Alice H Wang; Mark Liebow; Carrie A Thompson; Zachary S Fredericksen; William R Macon; Susan L Slager; Timothy G Call; Thomas M Habermann; James R Cerhan Journal: J Nutr Date: 2013-03-13 Impact factor: 4.798
Authors: Elizabeth A Hibler; Yann C Klimentidis; Peter W Jurutka; Lindsay N Kohler; Peter Lance; Denise J Roe; Patricia A Thompson; Elizabeth T Jacobs Journal: Nutr Cancer Date: 2015-08-04 Impact factor: 2.900